The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patterns and predictors of attendance at a comprehensive, multi-disciplinary supportive care program for men with prostate cancer and their partners.
 
Lindsay Hedden
No Relationships to Disclose
 
Phil Pollock
No Relationships to Disclose
 
Maria Spillane
No Relationships to Disclose
 
Monita Sundar
No Relationships to Disclose
 
Alan So
Honoraria - Astellas Pharma; Janssen
 
Peter C. Black
Consulting or Advisory Role - Abbvie; Allergan; Amgen; Astellas Pharma; Bayer; BioCancell; Biosyent; Cubist; Ferring; Janssen Oncology; Lilly; MDxHealth; Merck; Novartis; Roche Canada; Sanofi; Sitka; Spectrum Pharmaceuticals
Speakers' Bureau - Ferring; Red Leaf Medical
Research Funding - GenomeDx; iProgen; New B Innovation
Patents, Royalties, Other Intellectual Property - 1. PCT/CA2014/000787. Canada. 2014-11-03 Cancer Biomarkers and Classifiers and uses thereof. 2. #61899648 United States. 2013-03-13 Bladder cancer signature.
Travel, Accommodations, Expenses - Bayer; Janssen; Sanofi
 
Martin Gleave
Stock and Other Ownership Interests - OncoGenex
Honoraria - Abbvie; Astellas Pharma; Bayer; Janssen; Oncogenex; Sanofi
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Janssen; Oncogenex; Sanofi
Research Funding - Astellas Pharma; Bayer; Janssen
Patents, Royalties, Other Intellectual Property - OncoGenex - OGX-011, OGX-427
 
Larry Goldenberg
Leadership - Genyous
 
Celestia S. Higano
Employment - CTI (I)
Leadership - CTI (I)
Stock and Other Ownership Interests - CTI (I)
Consulting or Advisory Role - Asana Biosciences; Astellas Pharma; Bayer; Blue Earth Diagnostics; Churchill Pharmaceuticals; Clovis Oncology; Dendreon; Emergent BioSolutions; Endocyte; Ferring; Medivation; MorphoSys; Myriad Genetics; Orion; Parexel
Research Funding - Algeta/Bayer (Inst); Aragon Pharmaceuticals (Inst); AstraZeneca (Inst); Bayer (Inst); Dendreon (Inst); Emergent BioSolutions (Inst); Genentech (Inst); Medivation (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Asana Biosciences; Astellas Pharma; Bayer; Blue Earth Diagnostics; Churchill Pharmaceuticals; Clovis Oncology; Dendreon; Emergent BioSolutions; Emergent BioSolutions; Endocyte; Ferring; Genentech; Menarini; Myriad Genetics; Orion